Teva Pharmaceutical Industries (TEVA) FY2021 results: revenue $15.9 billion, down 4.7% on the year
Teva Pharmaceutical Industries Ltd. (TEVA) reported revenue of $15.9 billion for fiscal 2021, the year ended 31 December 2021, down 4.7% on the year before. Net income was $417 million, and diluted earnings per share $0.38. The figures are the company's own, from the 10-K it filed with the SEC on 9 February 2022.
Revenue
$15.9 billion
-4.7% on the year
FY2014FY2021
Operating margin
10.8%
-21.4% a year earlier
FY2014FY2021
Net income
$417 million
FY2014FY2021
Diluted EPS
$0.38
FY2014FY2021
this yearthe year beforeHover a bar for its figure.
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2021
FY2020
FY2019
On the year
Last 8 years
Operating cash flow
798
1,216
748
-34.4%
Capital expenditure
562
578
525
-2.8%
Free cash flow
236
638
223
-63.0%
Free cash flow margin
1.5%
3.8%
1.3%
Cash from investing
1,523
863
1,355
+76.5%
Cash from financing
-2,172
-1,885
-1,926
Depreciation and amortisation
1,330
1,557
1,722
-14.6%
Share-based compensation
119
129
119
-7.8%
Dividend per share
n/a
n/a
$0.00
Diluted shares, weighted
1,107m
1,095m
1,091m
+1.1%
Balance sheet
$ million
FY2021
FY2020
FY2019
On the year
Last 8 years
Shareholders' equity
10,278
10,026
13,972
+2.5%
Non-controlling interest
966
1,035
1,091
-6.7%
Debt
23,043
25,919
26,907
-11.1%
Operating lease liabilities
416
479
435
-13.2%
Other liabilities
12,963
13,181
15,065
-1.7%
Total liabilities and equity
47,666
50,640
57,470
-5.9%
Fixed assets
5,982
6,296
6,436
-5.0%
Goodwill
17,633
20,624
24,846
-14.5%
Intangible assets
7,466
8,923
11,232
-16.3%
Cash and equivalents
2,165
2,177
1,975
-0.6%
Receivables
4,529
4,581
5,676
-1.1%
Inventory
3,818
4,403
4,422
-13.3%
Other assets
6,073
3,636
2,883
+67.0%
Total assets
47,666
50,640
57,470
-5.9%
10-K for the year ended 31 December 2021, filed 9 February 2022: the filing.